Table 2 Primary and secondary outcomes based on ITT analyses with EM: means, standard deviations, effect sizes by group (WEP-CARE, TAU) and assessment time point (baseline, 3MFU, 6MFU) and results of repeated measures ANOVAs within two assessment time points (baseline and 3MFU) and the group variable (WEP-CARE, TAU)

GAD-7

7.81 (4.51)

0.83

6.47 (4.42)

3.90; p < .001

1.13

10.67 (4.39)

0.33

F1,206 = 35.68; p < .001

F1,35 = 6.13; p = .016

0.49

FoP-Q-SF

33.90 (9.65)

0.58

30.07 (6.47)

8.24; p < .001

1.22

41.30 (7.97)

− 0.16

F1,119 = 6.54; p = .013

F1,331 =

18.23; p < .001

0.71

PHQ-9

8.27 (4.76)

0.51

6.07 (4.04)

*

1.00

11.19 (4.77)

− 0.08

F1,41

= 5.97; p = .017

F1,74 = 10.79; p = .002

0.60

ULQIE

55.39 (4.85)

0.65

54.41 (3.23)

**

0.57

53.44 (4.94)

0.66

F1,1608 = 13.11; p = .001

F1,2 = 0.016; p = .899

0.29

CHIP-D

27.58 (7.43)

0.45

30.29

(6.27)

− 6,78; p = .001

0.79

23.21 (11.47)

− 0.08

F1,90 = 2.70; p = .105

F1,233 = 7.02;

p = .010

0.47